Search

everythinglearnresearchcommunity

for

Search:↓

Targeting mitophagy may help treat alopecia areata by reducing inflammasome activation.

The treatment might help COVID-19 related hair loss, but more research is needed.

High beta-hydroxybutyrate levels may worsen hair loss in alopecia areata.

Lower GATA3 levels in mice help hair regrow by changing certain immune cells.

Alopecia areata patients may have higher cardiovascular risk factors, so screening for metabolic syndrome components is suggested.

The symposium concluded that a specific lipid might cause hair loss, inflammation is a key factor, and stem cells in bald scalps aren't working right, suggesting new treatment targets.

Itraconazole effectively treated a woman's painful skin condition and hair loss.

Ritlecitinib may cause severe musculoskeletal pain in some alopecia universalis patients.

JAK inhibitors show promise for treating various skin diseases.

Imiquimod improved skin pigmentation in most patients with xeroderma pigmentosum and may prevent further skin cancer, but some treatments can have side effects.

Higher IgE levels may play a role in alopecia areata, especially in males, children, and severe cases.

Abatacept may help some people with alopecia areata regrow hair.

Gut bacteria differences could help diagnose and treat alopecia areata.

Early intervention in patch-type alopecia may prevent progression to more severe forms by targeting immune pathways and preserving keratin.

Combining stress management and Minoxidil helps treat stress-related hair loss and improve well-being.

Tofacitinib successfully treated vitiligo in a patient with lupus without side effects.

Tofacitinib helped a woman with total-body hair loss grow her hair back.

Discoid Lupus Erythematosus often causes scarring hair loss, is influenced by genetics and environment, and requires early treatment to prevent worsening.

The IRF2BP2 gene affects sheep fleece quality by influencing fiber traits.

Female-pattern hair loss may involve an autoimmune-like process, suggesting new treatment options.

TEC kinases may help cause inflammation in vitiligo and could be targeted for treatment.

Immune system changes may contribute to female pattern hair loss.

In alopecia areata, certain immune cells increase and express a protein linked to immune activation.

Contact immunotherapy can change immune responses in alopecia areata, suggesting new treatment targets.

JAK inhibitors show promise for treating skin disorders like alopecia, eczema, and psoriasis.

Alopecia areata is likely an autoimmune disease with unclear triggers, involving various immune cells and molecules, and currently has no cure.

The skin's internal clock affects healing, cancer risk, aging, immunity, and hair growth, and disruptions can harm skin health.

Janus kinase inhibitors are promising treatments for autoimmune skin diseases like eczema and psoriasis.

Oral tofacitinib can significantly improve recalcitrant lichen planopilaris.

A patient with alopecia areata regrew hair after taking tofacitinib and showed changes in certain blood and skin markers.